… observed in patients with COVID-19.1, 3 At the time of writing, there are ten ongoing clinical
trials in COVID-19 with the drug anakinra (table ). Anakinra inhibits the proinflammatory …

… Meaning This study did not find evidence of effectiveness of anakinra vs the standard of …
with severe COVID-19 pneumonia, and future research should assess anakinra in patients with …

… (suppression of C-reactive protein or fever) as important considerations. The use of … deci
sion making at the cusp of the COVID-19 pandemic. Several ongoing clinical trials will follow …

… with COVID-19. We aimed to assess the off-label use of anakinra in patients who were
admitted to hospital for severe forms of … A real-time dashboard of clinical trials for COVID-19. …

… In the present study, the effects of anakinra in critically ill COVID-19 patients with clinical …
These issues might have confounded the clinical outcome results demonstrated in these …

… or completed clinical trials on the use of anakinra in COVID-19 … Overall, 6 ongoing trials
were registered in the clinicaltrials.gov … Anakinra did not result in any critical safety issues when …

… anakinra may improve the patient's situation, and in this study, we … efficacy of anakinra in
patients diagnosed with COVID-19. … As an important consideration to our study, we administered …

… However, the role of Anakinra in COVID-19 remains unanswered, especially in patients …
and effects of Anakinra compared to placebo or standard care alone on clinical outcomes in …

… or laboratory signs of hyperinflammation, or both, or in the context of clinical trials, in an …
an important role in COVID-19 pathophysiology. We aimed to investigate the effect of anakinra …

… not observe a beneficial effect of anakinra in critically ill patients with COVID-19. Previous
studies and a recent meta-analysis provided a rationale for the use of anakinra in COVID-19. …